Total planned funding: $1,722,787,311
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $341,612,837 |
Nigeria | $291,529,578 |
Zambia | $284,833,664 |
Mozambique | $181,850,254 |
Uganda | $143,416,952 |
Zimbabwe | $80,214,693 |
Democratic Republic of the Congo | $51,997,724 |
South Africa | $41,180,455 |
Ethiopia | $35,740,601 |
Rwanda | $35,574,273 |
Haiti | $34,722,146 |
Eswatini | $34,427,904 |
Namibia | $34,355,746 |
Côte d'Ivoire | $19,014,717 |
Kenya | $15,592,252 |
Vietnam | $12,615,861 |
Ukraine | $10,232,589 |
Burundi | $9,815,894 |
Botswana | $9,695,528 |
Malawi | $9,548,536 |
West Africa Region | $9,096,491 |
Cameroon | $7,728,094 |
Lesotho | $6,364,620 |
Dominican Republic | $3,650,000 |
South Sudan | $3,041,359 |
Angola | $2,989,064 |
Central America Region | $2,529,008 |
Asia Regional Program | $2,460,112 |
Western Hemisphere Region | $2,048,556 |
Indonesia | $1,300,000 |
Caribbean Region | $1,071,844 |
Ghana | $1,010,959 |
Cambodia | $650,000 |
Burma | $500,000 |
enumerations.Sierra Leone | $375,000 |
Central Asia Region | $0 |
Organizational Types
Private Contractor | $1,722,787,311 |
Program Areas
Treatment | $1,164,140,675 |
Care | $228,985,016 |
Prevention | $134,316,673 |
Testing | $100,781,426 |
Governance and Systems | $94,438,021 |
Management and Operations | $125,500 |
Budget Codes
HTXD: Treatment: ARV Drugs | $625,068,029 |
HTXS: Treatment: Adult Treatment | $462,856,614 |
HVCT: Testing: HIV Testing and Counseling | $100,781,426 |
HKID: Care: Orphans and Vulnerable Children | $93,499,971 |
PDTX: Treatment: Pediatric Treatment | $76,216,032 |
OHSS: Health Systems Strengthening | $68,973,936 |
HVOP: Sexual Prevention: Other Sexual Prevention | $59,933,633 |
HVTB: Care: TB/HIV | $57,507,499 |
HBHC: Care: Adult Care and Support | $49,596,886 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $45,427,024 |
PDCS: Care: Pediatric Care and Support | $28,380,660 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $21,335,220 |
HVSI: Strategic Information | $13,966,654 |
HLAB: Laboratory Infrastructure | $11,497,431 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $6,420,548 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $913,248 |
HMIN: Biomedical Prevention: Injection Safety | $287,000 |
HVMS: Management and Operations | $125,500 |
HMBL: Biomedical Prevention: Blood Safety | $0 |
Top Partner Programs
Chemonics International:
$1,242,734,233
View countries